SMURF1
Basic information
Region (hg38): 7:99027440-99144108
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMURF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 27 | 2 | 2 |
Variants in SMURF1
This is a list of pathogenic ClinVar variants found in the SMURF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-99030655-C-T | not specified | Uncertain significance (Feb 02, 2024) | ||
7-99030675-C-T | not specified | Uncertain significance (Jun 06, 2022) | ||
7-99033104-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
7-99033116-T-C | not specified | Uncertain significance (May 27, 2022) | ||
7-99035506-G-A | Benign (Feb 20, 2018) | |||
7-99035601-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
7-99037119-T-C | not specified | Uncertain significance (Aug 01, 2023) | ||
7-99038389-G-A | not specified | Uncertain significance (May 27, 2022) | ||
7-99038400-T-G | not specified | Uncertain significance (May 01, 2022) | ||
7-99038452-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
7-99040487-T-A | not specified | Uncertain significance (Nov 10, 2022) | ||
7-99040496-G-A | Uncertain significance (May 27, 2022) | |||
7-99042136-C-T | Likely benign (Oct 01, 2023) | |||
7-99042164-T-G | not specified | Uncertain significance (Aug 21, 2023) | ||
7-99047708-T-C | Likely benign (Jul 01, 2022) | |||
7-99047734-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
7-99047752-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
7-99047860-G-A | not specified | Uncertain significance (Oct 24, 2023) | ||
7-99049628-T-C | not specified | Uncertain significance (Aug 17, 2021) | ||
7-99049631-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
7-99050949-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
7-99052205-C-T | not specified | Uncertain significance (Mar 25, 2021) | ||
7-99052235-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
7-99052279-T-A | not specified | Uncertain significance (Dec 28, 2022) | ||
7-99052321-C-T | not specified | Uncertain significance (Dec 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMURF1 | protein_coding | protein_coding | ENST00000361125 | 19 | 116663 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.612 | 0.388 | 125739 | 0 | 8 | 125747 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.76 | 282 | 446 | 0.632 | 0.0000270 | 4948 |
Missense in Polyphen | 73 | 161.95 | 0.45075 | 1812 | ||
Synonymous | -0.364 | 201 | 195 | 1.03 | 0.0000136 | 1457 |
Loss of Function | 4.99 | 10 | 46.9 | 0.213 | 0.00000267 | 491 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that acts as a negative regulator of BMP signaling pathway. Mediates ubiquitination and degradation of SMAD1 and SMAD5, 2 receptor-regulated SMADs specific for the BMP pathway. Promotes ubiquitination and subsequent proteasomal degradation of TRAF family members and RHOA. Promotes ubiquitination and subsequent proteasomal degradation of MAVS (PubMed:23087404). Plays a role in dendrite formation by melanocytes (PubMed:23999003). {ECO:0000269|PubMed:10458166, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:21402695, ECO:0000269|PubMed:23087404, ECO:0000269|PubMed:23999003}.;
- Pathway
- TGF-beta signaling pathway - Homo sapiens (human);Endocytosis - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);Hedgehog signaling pathway - Homo sapiens (human);TGF-Ncore;Bone Morphogenic Protein (BMP) Signalling and Regulation;Ectoderm Differentiation;TGF-beta Signaling Pathway;Hedgehog Signaling Pathway;Transcriptional regulation by RUNX2;Regulation of RUNX3 expression and activity;Signaling by WNT;Signal Transduction;Gene expression (Transcription);Transcriptional regulation by RUNX3;estrogen responsive protein efp controls cell cycle and breast tumors growth;Generic Transcription Pathway;RNA Polymerase II Transcription;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;TGF-beta super family signaling pathway canonical;Hedgehog ,on, state;Signaling by Hedgehog;Asymmetric localization of PCP proteins;TGF_beta_Receptor;PCP/CE pathway;BMP receptor signaling;Beta-catenin independent WNT signaling;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Signaling by TGF-beta family members;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Signaling events mediated by HDAC Class I;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);TGF-beta receptor signaling;Regulation of RUNX2 expression and activity
(Consensus)
Recessive Scores
- pRec
- 0.169
Intolerance Scores
- loftool
- 0.239
- rvis_EVS
- -1.38
- rvis_percentile_EVS
- 4.39
Haploinsufficiency Scores
- pHI
- 0.345
- hipred
- Y
- hipred_score
- 0.792
- ghis
- 0.622
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smurf1
- Phenotype
- growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;ubiquitin-dependent protein catabolic process;protein export from nucleus;transforming growth factor beta receptor signaling pathway;ectoderm development;protein ubiquitination;cell differentiation;negative regulation of ossification;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;ubiquitin-dependent SMAD protein catabolic process;receptor catabolic process;protein localization to cell surface;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of protein catabolic process;Wnt signaling pathway, planar cell polarity pathway;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;engulfment of target by autophagosome;substrate localization to autophagosome;protein targeting to vacuole involved in autophagy;protein localization to plasma membrane;positive regulation of dendrite extension;positive regulation of ubiquitin-dependent protein catabolic process
- Cellular component
- nucleoplasm;cytoplasm;mitochondrion;cytosol;plasma membrane;axon;neuronal cell body;extracellular exosome
- Molecular function
- ubiquitin-protein transferase activity;protein binding;phospholipid binding;activin binding;ubiquitin protein ligase activity;I-SMAD binding;R-SMAD binding